全球靜脈輸液治療市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計靜脈輸液療法的市場規模將從 2025 年的 36.8 億美元成長到 2034 年的 74.3 億美元，2026 年至 2034 年的複合年成長率為 8.13%。

全球靜脈輸液療法市場正經歷強勁成長，這主要得益於人們對健康促進和預防性醫療保健解決方案日益成長的需求。與口服補充劑相比，靜脈輸液療法具有吸收速度更快的優勢，可直接將液體、維生素和電解質輸送到血液中。運動員、繁忙的商務人士以及尋求快速緩解脫水和疲勞的人群對靜脈輸液療法的需求不斷成長，推動了市場擴張。專業健康診所和行動靜脈輸液服務（移動式IV服務）的興起進一步加速了靜脈輸液療法的普及。

關鍵成長要素包括人們對免疫支持和個人化營養管理的認知不斷提高。都市區的成長和生活方式的改變正在推動對便利健康解決方案的需求。靜脈輸液設備的科技進步和安全通訊協定的改善提高了病患的舒適度和可靠性。此外，在醫院環境中，輸液和術後護理的日益普及也鞏固了市場基礎。

展望未來，居家醫療和按需醫療服務的擴張預計將對市場產生正面影響。新興市場可支配收入的成長將創造新的機會。醫療服務提供者正專注於在醫療監督下提供客製化的維生素配方和療法。隨著預防醫學趨勢的持續發展，全球靜脈輸液治療市場預計將穩定成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球靜脈輸液治療市場：依服務類型分類

• 市場分析、洞察與預測
• 免疫增強劑
• 能量增強劑
• 護膚
• 偏頭痛
• 其他

第5章 全球靜脈輸液治療市場：依成分分類

• 市場分析、洞察與預測
• 藥用
• 非藥品

第6章：全球靜脈輸液治療市場：依最終用途分類

• 市場分析、洞察與預測
• 醫院和診所
• 健康中心和水療中心
• 居家醫療
• 其他

第7章 全球靜脈輸液治療市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Core IV Therapy LLC
  • Cryojuvenate UK Ltd
  • B. Braun Medical Inc
  • Otsuka Pharmaceutical Co. Ltd
  • NexGen Health
  • JW Life Science Corporation
  • Amanta Healthcare
  • Baxter International Inc
  • Drip Hydration
  • Nikkiso Co Ltd

The IV Hydration Therapy Market size is expected to reach USD 7.43 Billion in 2034 from USD 3.68 Billion (2025) growing at a CAGR of 8.13% during 2026-2034.

The Global IV Hydration Therapy Market is witnessing strong growth driven by rising demand for wellness and preventive healthcare solutions. IV hydration therapy delivers fluids, vitamins, and electrolytes directly into the bloodstream, ensuring faster absorption compared to oral supplements. Increasing popularity among athletes, busy professionals, and individuals seeking rapid recovery from dehydration or fatigue is supporting market expansion. Growth of specialized wellness clinics and mobile IV services is further boosting adoption.

Key growth drivers include increasing awareness about immunity support and personalized nutrition. Expanding urban populations and changing lifestyles are encouraging demand for convenient health solutions. Technological advancements in infusion devices and safety protocols are enhancing patient comfort and reliability. Additionally, rising use in hospital settings for rehydration and post-operative care is strengthening the market base.

Looking ahead, the market is expected to benefit from expansion of home-based and on-demand healthcare services. Emerging markets with growing disposable incomes will create new opportunities. Providers are focusing on customized vitamin blends and medically supervised therapies. As preventive healthcare trends continue to rise, the Global IV Hydration Therapy Market is projected to expand steadily.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Service

• Immune Boosters
• Energy Boosters
• Skin Care
• Migraine
• Others

By Component

• Medicated
• Non-medicated

By End-use

• Hospitals & Clinics
• Wellness Centers & Spas
• Home Healthcare
• Others

COMPANIES PROFILED

• Core IV Therapy LLC, Cryojuvenate UK Ltd, B Braun Medical Inc, Otsuka Pharmaceutical Co Ltd, NexGen Health, JW Life Science Corporation, Amanta Healthcare, Baxter International Inc, Drip Hydration, Nikkiso Co Ltd
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL IV HYDRATION THERAPY MARKET: BY SERVICE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Service
• 4.2. Immune Boosters Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Energy Boosters Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Skin Care Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Migraine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL IV HYDRATION THERAPY MARKET: BY COMPONENT 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Component
• 5.2. Medicated Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Non-medicated Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL IV HYDRATION THERAPY MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Wellness Centers & Spas Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Home Healthcare Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL IV HYDRATION THERAPY MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Service
  • 7.2.2 By Component
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Service
  • 7.3.2 By Component
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Service
  • 7.4.2 By Component
  • 7.4.3 By End-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Service
  • 7.5.2 By Component
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Service
  • 7.6.2 By Component
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL IV HYDRATION THERAPY INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Core IV Therapy LLC
  • 9.2.2 Cryojuvenate UK Ltd
  • 9.2.3 B. Braun Medical Inc
  • 9.2.4 Otsuka Pharmaceutical Co. Ltd
  • 9.2.5 NexGen Health
  • 9.2.6 JW Life Science Corporation
  • 9.2.7 Amanta Healthcare
  • 9.2.8 Baxter International Inc
  • 9.2.9 Drip Hydration
  • 9.2.10 Nikkiso Co Ltd